RetailBooze in the Ozempic-era: Coles to capitalise on GLP-1 craze
Coles chief executive Leah Weckert is hoping to capitalise on the popularity of weight-loss drugs, like Ozempic and Mounjaro, to arrest declining sales at its struggling liquor division.